Top Biotech Gainers: ADVB Soars Over 200% In A Week, NVCR, MEDP Report Q2 Results, AGMB In Focus

rttnews.com · 2026-07-24

Today's top biotech gainers include Advanced Biomed, which led the rally with a gain of more than 200% over the past week. Novocure climbed following strong Q2 results and a revised full-year revenue outlook, while Medpace gained on solid quarterly performance and a positive outlook, among others.

TickrTrends take: MEDP reported Q2 results according to recent market activity, which provides investors with updated financial information to assess the company's operational performance. Given TickrTrends' current overvalued designation for MEDP, valuation-focused readers should carefully examine whether the Q2 results justify the stock's current price relative to fundamental metrics in the competitive Healthcare sector. The earnings report offers an opportunity to evaluate whether MEDP's valuation multiples align with its actual earnings power and growth trajectory.

Read the full story at rttnews.com →